TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy.

Oncoimmunology · 2012 · PMC3518499 · PMID 23243590

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

29 In line with this observation, we observed highly significant MUC1-specific IFNγ responses using splenocytes from mice treated with the combination of MVA-MUC1 with Pam3Cys.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.